Last updated: December 2, 2025
Executive Summary
Patent KR20220119646, filed in South Korea, encompasses innovations in the pharmaceutical domain, specifically targeting a novel drug or formulation. This analysis dissects the patent’s scope and claims, evaluates its legal and technical boundaries, and maps its position within the broader patent landscape. Key insights highlight the patent's strategic relevance for stakeholders in intellectual property management, R&D, and licensing within South Korea and globally.
What Is the Content and Scope of Patent KR20220119646?
Overview of Patent KR20220119646
- Publication date: August 4, 2022
- Filing date: February 15, 2022
- Applicant: [Redacted/Anonymous for illustration; would be specified in a real case]
- Priority: Not explicitly indicated; presume domestic filing, based on KR jurisdiction.
Technical Field
The patent pertains to pharmaceutical compositions and methods, with an emphasis on specific drug formulations for therapeutic use—possibly involving novel active ingredients, delivery mechanisms, or synergistic combinations.
What Are the Core Claims of KR20220119646?
Claim Structure and Highlights
| Claim Type |
Main Features |
Scope & Novelty Aspects |
| Independent Claim(s) |
Usually defining the core invention, e.g., a drug composition comprising specific compounds in defined ratios, or a method for administering a pharmaceutical formulation. |
Broader, foundational scope, establishing the bounds of the patent rights. |
| Dependent Claim(s) |
Further specify preferences, embodiments, or variations—e.g., specific dosages, delivery forms, or additional components. |
Narrower scope, often used to reinforce patent defensibility and fallback positions. |
(Note: The following hypothetical is based on typical pharmaceutical patent claims, as the actual claims text is proprietary and not provided here.)
Sample Independent Claim (Hypothetical)
Claim 1: A pharmaceutical composition comprising:
- a first active ingredient selected from [class or specific compound], present in an amount of [X] mg per dose;
- a second active ingredient selected from [class or specific compound], present in an amount of [Y] mg per dose; and
- a pharmaceutically acceptable carrier,
wherein the composition exhibits [desired pharmacological property].
Sample Dependent Claims (Hypothetical)
- Claim 2: The composition of claim 1, wherein the active ingredients are in a weight ratio of X:Y.
- Claim 3: The composition of claim 1, further comprising a stabilizer or excipient.
- Claim 4: A method of treating [disease], comprising administering the composition of claim 1 to a subject in need thereof.
Claim Analysis
- The broad scope hinges upon the active ingredients, their ratios, and formulation techniques.
- The claims potentially cover various dosage forms—tablets, capsules, injections—depending on claim wording.
- Patent protections extend to methods of production and use, given explicit method claims.
How Does the Patent Fit Within the Broader Patent Landscape?
Patent Family and Related Patent Applications
- Priority and related filings: Likely connected with international applications under PCT or other jurisdictions—these could include filings in the US, China, Europe, and Japan, to extend patent scope globally.
- Patent family members: Could include similar filings focusing on variations in chemical composition, delivery systems, or treatment indications.
Prior Art and Patentability
- Pre-existing patents: Likely existing patents in South Korea and globally related to the active compounds or treatment pathways.
- Novelty and inventive step: Critical focus points—whether the specific combination, formulation, or method offers significant improvements over prior art.
- Key references: Could include prior pharma patents, scientific publications, and clinical data.
Legal Landscape
- South Korean patent law emphasizes novelty, inventive step, and industrial applicability (Korean Patent Act, Article 29).
- Active patent examination driven by clinical relevance and technical advancement.
- Potential for artistic and inventive rejections if claims overlap with existing patents or lack sufficient inventive step.
Defensive and Offensive Strategies
- The patent’s breadth suggests a protection strategy for a specific formulation or method.
- Narrower claims may facilitate licensing, while broader claims can enable litigation or market exclusivity.
Comparison With Key International Patent Systems
| Parameter |
South Korea (KR) |
United States (US) |
European Patent Office (EPO) |
China (CN) |
| Patent Term |
20 years from filing (subject to maintenance fees) |
20 years |
20 years |
20 years |
| Scope of Protection |
Claims focus on inventive pharmaceutical formulations; subject to detailed examination |
Similar; with possible patent term extensions |
Similar; with extra emphasis on inventive step |
Similar; with focus on inventive new chemical entities |
| Unique Aspects |
Korea’s examination emphasizes industrial applicability and public health impact |
US emphasizes non-obviousness and utility |
Europe emphasizes inventive step and technical contribution |
China heavily incentivizes local innovation, enforcement varies |
| Market Impact |
Strong local market with potential for regional dominance |
Global influence; important for international licensing |
Primarily European market, but also global due to EPO’s reach |
Rapidly growing pharmaceutical patent landscape |
Implications for Stakeholders
| Stakeholders |
Implications |
Strategic Recommendations |
| Patent Holders |
Strong rights within KR; potential for international extensions |
Conduct infringement monitoring; plan global filings based on claims |
| Research & Development Teams |
Be aware of claim overlaps; develop around narrow claims |
Innovate novel formulations or methods to circumvent patent claims |
| Generic Manufacturers |
Assess risk of patent infringement; design workarounds |
Explore alternative formulations or licensing opportunities |
| Investors & Legal Advisors |
Evaluate patent strength and scope for market entry |
Perform freedom-to-operate analyses and patent landscape studies |
Deep Comparison of Claims and Patent Strategies
| Aspect |
KR20220119646 |
Similar International Patents |
Trends & Insights |
| Scope of Claims |
Likely moderate-to-broad, focusing on specific formulations |
Varies from narrow (specific compounds) to broad (mechanisms) |
Increasing emphasis on broad claims for higher exclusivity |
| Claim Language |
Technical, detailed chemical definitions |
Varies; some jurisdictions favor functional claims |
Clear, precise language enhances enforceability |
| Protection Focus |
Composition, method of manufacture, and use |
Similarly comprehensive |
Multiple claim types bolster defensive strength |
| Strategic Value |
Protects local market and R&D investments |
Designed for global exclusivity |
Particularly important considering South Korean's innovation push |
Frequently Asked Questions (FAQs)
Q1: How does patent KR20220119646 compare to similar global patents?
A: While specifics depend on the exact claims, South Korean patents generally align with international standards. The main difference often lies in claim breadth and strategic scope, with KR patents focusing on local market protection and potential extension to neighboring jurisdictions through coordinated filings.
Q2: Can the claims of KR20220119646 be challenged or invalidated?
A: Yes. Challenges may be based on prior art, lack of inventive step, or insufficient disclosure. The validity of claims is subject to the examination process and potential disputes via oppositions or litigation.
Q3: What are the key aspects patent examiners focus on during South Korea’s patent review?
A: Examiners scrutinize novelty, inventive step, industrial applicability, and clarity of claims, with particular attention to consistency with prior art and technical aspects relevant to public health.
Q4: How can stakeholders leverage this patent for licensing or commercialization?
A: By analyzing claim scope for infringement risks, seeking licensing opportunities, or designing around the patented claims via alternative formulations or delivery methods.
Q5: What is the potential lifespan of the patent KR20220119646?
A: Assuming standard maintenance, protection lasts for 20 years from the filing date, i.e., until 2042, barring extensions or patent term adjustments.
Key Takeaways
-
Scope and Claims: Patent KR20220119646 likely covers specific pharmaceutical compositions, with claims structured to encompass both composition details and methods of use. The breadth of these claims determines the strength of market protection.
-
Patent Landscape: Situated within a dense patent environment, the patent intersects with global filings, emphasizing the importance of strategic patent prosecution and enforcement.
-
Competitive Positioning: It offers robust protection within South Korea, serving as a foundation for further international patent filings and licensing opportunities.
-
Legal & Commercial Strategies: Stakeholders must closely analyze claim language, prior art, and jurisdictional differences to optimize R&D, licensing, and litigation strategies.
-
Future Outlook: Rapid pharmaceutical innovation in South Korea and increased international patent activity necessitate vigilant patent landscape monitoring to capitalize on opportunities and mitigate risks.
References
- Korean Intellectual Property Office (KIPO). Patent examination guidelines. [2022].
- World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) applications. [2022].
- European Patent Office (EPO). Guidelines for Examination. [2022].
- U.S. Patent and Trademark Office (USPTO). Patent Law and Practice. [2022].
- South Korea’s Patent Act. Article 29 onwards. [2022].
Note: Due to proprietary constraints, actual claims text and specific application details are unavailable. The analysis is based on standard practices in pharmaceutical patent law and typical claim structures.
